Hasil Pencarian - M Connock

Perbaiki Hasil
  1. 1
    A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept

    A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept oleh C. Cummins, M. Connock, A. Fry-Smith, A. Burls

    Diterbitkan 2002-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Sorafenib for the treatment of advanced hepatocellular carcinoma

    Sorafenib for the treatment of advanced hepatocellular carcinoma oleh M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Sorafenib for the treatment of advanced hepatocellular carcinoma

    Sorafenib for the treatment of advanced hepatocellular carcinoma oleh M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Infliximab for the treatment of acute exacerbations of ulcerative colitis

    Infliximab for the treatment of acute exacerbations of ulcerative colitis oleh S Bryan, L Andronis, C Hyde, M Connock, A Fry-Smith, D Wang

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Infliximab for the treatment of acute exacerbations of ulcerative colitis

    Infliximab for the treatment of acute exacerbations of ulcerative colitis oleh S Bryan, L Andronis, C Hyde, M Connock, A Fry-Smith, D Wang

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression

    A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compres... oleh P Sutcliffe, M Connock, D Shyangdan, R Court, N-B Kandala, A Clarke

    Diterbitkan 2013-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis

    'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis oleh D Wang, M Connock, P Barton, A Fry-Smith, P Aveyard, D Moore

    Diterbitkan 2008-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia

    Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia oleh J Dretzke, P Barton, B Kaambwa, M Connock, O Uthman, S Bayliss, C Meads

    Diterbitkan 2010-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia

    Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia oleh R Edlin, M Connock, S Tubeuf, J Round, A Fry-Smith, C Hyde, W Greenheld

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling

    Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling oleh M Connock, C Stevens, A Fry-Smith, S Jowett, D Fitzmaurice, D Moore, F Song

    Diterbitkan 2007-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis

    Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis oleh M Connock, S Tubeuf, K Malottki, A Uthman, J Round, S Bayliss, C Meads, D Moore

    Diterbitkan 2010-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia

    Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia oleh R Edlin, M Connock, S Tubeuf, J Round, A Fry-Smith, C Hyde, W Greenheld

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation

    Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation oleh J Wilson, M Connock, F Song, G Yao, A Fry-Smith, J Raftery, D Peake

    Diterbitkan 2005-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review

    Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review oleh DA Lane, S Raichand, D Moore, M Connock, A Fry-Smith, DA Fitzmaurice, on behalf of the Steering Committee

    Diterbitkan 2013-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1

    A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1 oleh M Connock, A Juarez-Garcia, E Frew, A Mans, J Dretzke, A Fry-Smith, D Moore

    Diterbitkan 2006-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews

    Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews oleh P Sutcliffe, M Connock, T Gurung, K Freeman, S Johnson, N-B Kandala, A Grove, B Gurung, S Morrow, A Clarke

    Diterbitkan 2013-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review

    The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review oleh M Connock, E Frew, B-W Evans, S Bryan, C Cummins, A Fry-Smith, A Li Wan Po, J Sandercock

    Diterbitkan 2006-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours

    Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours oleh J Dretzke, J Round, M Connock, S Tubeuf, M Pennant, A Fry-Smith, C Hulme, C McCabe, C Meads

    Diterbitkan 2010-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease

    A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease oleh J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, C McCabe, C Meads

    Diterbitkan 2011-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model

    Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults... oleh P Sutcliffe, M Connock, R Pulikottil-Jacob, N-B Kandala, G Suri, T Gurung, A Grove, D Shyangdan, S Briscoe, H Maheswaran, A Clarke

    Diterbitkan 2013-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: